Site Search

Press Releases

New OCT Model Added to Spectralis Product Line – Spectral-Domain OCT with Eye Tracking (04/26/07)

Heidelberg Engineering Expands Spectralis™ Family of Products, Merging Spectral-Domain OCT and Eye Tracking Technology VISTA, CALIFORNIA and HEIDELBERG, GERMANY– April 26, 2007 – Heidelberg Engineering
Continue Reading

Heidelberg Engineering Receives FDA Clearance for World’s First Spectral-Domain OCT and Laser Angiography Instrument (11/03/06)

Spectralis™ HRA+OCT reveals previously undetected retinal structures VISTA, CALIFORNIA and HEIDELBERG, GERMANY– November 3, 2006 – Heidelberg Engineering GmbH, the leading developer of laser
Continue Reading

Heidelberg Retina Tomograph (HRT) Retina Module Premium Edition Features Edema Indexes and Retinal-Thickness-Measuring Capabilities (11/01/06)

New Retina Module Premium Edition enhances ability to detect and track retinal pathologies VISTA, CALIFORNIA – November 1, 2006 – Heidelberg Engineering, the leading developer
Continue Reading

Heidelberg Engineering Announces New Features For HRA 2 (10/16/06)

New value-added features enhance imaging technologies using Automatic Real-Time (ART™) software VISTA, CALIFORNIA – October 16, 2006 – Heidelberg Engineering announces new software features
Continue Reading

Heidelberg Engineering Receives FDA Clearance for Slit Lamp-Mounted Anterior Segment OCT (02/09/06)

FDA clears world’s first commercial OCT device for cross-sectional anterior segment imaging. HEIDELBERG, Germany — Feb. 9, 2006 — Heidelberg Engineering GmbH has received
Continue Reading

OHTS Results Released: HRT is Predictive of Glaucoma at First Visit (09/14/05)

HRT is clinically validated to be a powerful and accurate predictor of glaucoma  DOSSENHEIM, Germany – Sept. 14, 2005 - Heidelberg Engineering GmbH, the leading
Continue Reading

New HRT3 Introduced (09/01/05)

Heidelberg Engineering launches HRT3 to facilitate early glaucoma diagnosis; new device is portable, easy to use and can analyze glaucoma progression DOSSENHEIM, GERMANY– Sept.
Continue Reading

1